Similar articles

• Safety evaluation of penfluridol, a new long-acting oral antipsychotic agent.

  Ota KY, Kurland AA, Slotnick VB. Ota KY, et al. J Clin Pharmacol. 1974 Apr;14(4):202-9. doi: 10.1002/j.1552-4604.1974.tb01398.x. J Clin Pharmacol. 1974. PMID: 4595986 Clinical Trial. No abstract available.
• Penfluridol: a long-acting oral neuroleptic as therapeutic agent in chronic schizophrenia.

  Jus A, Pineau R, Jus K, Villeneuve A, Gautier J, Pires P, Drolet A, Cote M, Villeneuve R. Jus A, et al. Curr Ther Res Clin Exp. 1974 Oct;16(10):1041-58. Curr Ther Res Clin Exp. 1974. PMID: 4215617 Clinical Trial. No abstract available.
• Penfluridol (R 16341). A long-acting oral neuroleptic, as maintenance therapy for schizophrenic and mentally retarded patients. A placebo-controlled double-blind trial.

  Zwanikken GJ. Zwanikken GJ. Psychiatr Neurol Neurochir. 1973 Mar-Apr;76(2):83-92. Psychiatr Neurol Neurochir. 1973. PMID: 4573494 Clinical Trial. No abstract available.
• [Long-acting neuroleptics. 3. Pilot study of penfluridol (R16341): psychometric data].

  Mormont C. Mormont C. Acta Psychiatr Belg. 1972 Sep;72(5):595-601. Acta Psychiatr Belg. 1972. PMID: 4669431 French. No abstract available.
• A comparison of equivalent clinical potencies of neuroleptics as used to treat schizophrenia and affective disorders.

  Wyatt RJ, Torgow JS. Wyatt RJ, et al. J Psychiatr Res. 1977;13(2):91-8. doi: 10.1016/0022-3956(77)90011-5. J Psychiatr Res. 1977. PMID: 320322 Review. No abstract available.